CLINICAL TRIAL: STIFFNESS

PROVEN REDUCTION IN JOINT PAIN AND STIFFNESS

Clinical trials tested the effects of a daily dose of Tri-HELIX COMPLEX™ on the symptoms of osteoarthritis in elderly woman.
A randomised, double blind, placebo – controlled clinical study was performed on a 100 women between the ages of 40 years – 70 years. The Clinical trial was conducted over a period of 6 months.
Results showed the significant decrease in joint pain and stiffness, including an improvement in joint function. The Lysholm score significantly improved (evaluates knee function, by integrating information on limping, stair climbing, locking, giving way of the knee during activity and the ability to squat the joint.)
The Womac score – (calculating pain, stiffness and functional limitation of joints) decreased rapidly during the course of the clinical trial.

399 patients were randomised, aged 62 (35–84) years, 54% women, mean body mass index 27 (SD 4) kg/m2, mean symptom duration 4 (SD 5) years, 0–100 normalised Lequesne Index 30 (SD 9) and global pain visual analogue scale 37 (SD 23) mm.
There were 20% less progressors in the ASU-E than in the placebo group (40% vs 50%, respectively, p=0.040). Safety was excellent.